Family B QOC Annual % of family members reporting y/n Star & Annual Support EOC positive experience w family member survey support services Care planning with B EOC Annual % of members and/or family y/n Survey Annual member/family reporting inclusion in goal development and care planning Education B QOC Annual % of members and/or family who y/n Member survey Annual report having adequate or higher level of knowledge re: reason, symptomology, and remediation of side effects of prescribed medications Education A OC Annual % of individuals ages 18 & > with MCO Quarterly Adherence to HEDIS schizophrenia or schizoaffective Antipsychotic disorder who had at least 2 rx drug Medications for claims for antipsychotic Individuals with medications and had a Proportion Schizophrenia of Days Covered (PDC) of at least 0.8 for antipsychotic medications during the measurement period (12 consecutive months). Antidepressant A QOC Annual % of members ages 18 and > who y/n MCO Quarterly medication HEDIS had a new diagnosis of depression management and treated with an antidepressant medication who remained on the antidepressant for acute phase and recovery phase of treatment Knowledge of B EOC Annual % of members and/or family who y/n Member survey Annual condition(s) report having adequate or higher level of knowledge of condition(s) Goal IV: Improve quality of life for members with SMI/SED (Recovery & Resiliency)
Family Support B QOC EOC Annual % of family members reporting positive experience w family support services y/n Star & member survey Annual Care planning with member/family B EOC Annual % of members and/or family reporting inclusion in goal development and care planning y/n Survey Annual Education B QOC Annual % of members and/or family who report having adequate or higher level of knowledge re: reason, symptomology, and remediation of side effects of prescribed medications y/n Member survey Annual Education Adherence to Antipsychotic Medications for Individuals with Schizophrenia A OC HEDIS Annual % of individuals ages 18 & > with schizophrenia or schizoaffective disorder who had at least 2 rx drug claims for antipsychotic medications and had a Proportion of Days Covered (PDC) of at least 0.8 for antipsychotic medications during the measurement period (12 consecutive months). MCO Quarterly Antidepressant medication management A QOC HEDIS Annual % of members ages 18 and > who had a new diagnosis of depression and treated with an antidepressant medication who remained on the antidepressant for acute phase and recovery phase of treatment y/n MCO Quarterly Knowledge of condition(s) B EOC Annual % of members and/or family who report having adequate or higher level of knowledge of condition(s) y/n Member survey Annual Goal IV: Improve quality of life for members with SMI/SED (Recovery & Resiliency)
Provider%20Pol%20Manual%20MP%20SW%2011_30_17.docx